Meeting
2018 ASCO Annual Meeting
Alterations in key clear cell renal cell carcinoma (RCC) genes to refine patient prognosis.
Authors
Dominick Bossé
Dana-Farber Cancer Institute, Boston, MA
Dominick Bossé , Wanling Xie , Yasser Ged , Andrew W Hahn , Paulo Gustavo Bergerot , Thai Huu Ho , Rana R. McKay , Tracy Lynn Rose , Guillermo de Velasco , Nizar M. Tannir , Pheroze Tamboli , Leonard Joseph Appleman , Kimryn Rathmell , A. Ari Hakimi , Sumanta K. Pal , Neeraj Agarwal , Daniel Yick Chin Heng , Sabina Signoretti , Martin Henner Voss , Toni K. Choueiri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Citation
J Clin Oncol 36, 2018 (suppl; abstr 4516)
DOI
10.1200/JCO.2018.36.15_suppl.4516
Abstract #
4516
Poster Bd #
342
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
Genomic alterations to refine prognostication of patients with metastatic renal cell carcinoma.
First Author: Dominick Bosse
Poster
2023 ASCO Annual Meeting
Genomic determinants of progression-free survival after second line of therapy (PFS-2) for patients on immunotherapy-based combination therapies for advanced clear cell renal cell carcinoma.
First Author: Kelly N. Fitzgerald
Poster
2020 ASCO Virtual Scientific Program
Clinically advanced renal cell carcinoma (RCC) and renal sarcoma (RSC) in young patients: A comprehensive genomic profiling (CGP) study.
First Author: Gennady Bratslavsky
Poster
2020 ASCO Virtual Scientific Program
Comprehensive genomic profiling of 216 Chinese patients with renal cell carcinoma.
First Author: Congwang Zhang